The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neuroscience Antibodies and Assays-Global Market Insights and Sales Trends 2024
Synopsis
The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.
The global Neuroscience Antibodies and Assays market size is expected to reach US$ 3691.5 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroscience Antibodies and Assays in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers,, are propelling Neuroscience Antibodies and Assays market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuroscience Antibodies and Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuroscience Antibodies and Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroscience Antibodies and Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroscience Antibodies and Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroscience Antibodies and Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroscience Antibodies and Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroscience Antibodies and Assays covered in this report include Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend and Santa Cruz Biotechnology, etc.
The global Neuroscience Antibodies and Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens
Global Neuroscience Antibodies and Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroscience Antibodies and Assays market, Segment by Type:
Consumables
Instruments
Global Neuroscience Antibodies and Assays market, by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuroscience Antibodies and Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.
The global Neuroscience Antibodies and Assays market size is expected to reach US$ 3691.5 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroscience Antibodies and Assays in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers,, are propelling Neuroscience Antibodies and Assays market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuroscience Antibodies and Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuroscience Antibodies and Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroscience Antibodies and Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroscience Antibodies and Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroscience Antibodies and Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroscience Antibodies and Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroscience Antibodies and Assays covered in this report include Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend and Santa Cruz Biotechnology, etc.
The global Neuroscience Antibodies and Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens
Global Neuroscience Antibodies and Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroscience Antibodies and Assays market, Segment by Type:
Consumables
Instruments
Global Neuroscience Antibodies and Assays market, by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuroscience Antibodies and Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neuroscience Antibodies and Assays
1.1 Neuroscience Antibodies and Assays Market Overview
1.1.1 Neuroscience Antibodies and Assays Product Scope
1.1.2 Neuroscience Antibodies and Assays Market Status and Outlook
1.2 Global Neuroscience Antibodies and Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuroscience Antibodies and Assays Market Size by Region (2018-2029)
1.4 Global Neuroscience Antibodies and Assays Historic Market Size by Region (2018-2023)
1.5 Global Neuroscience Antibodies and Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuroscience Antibodies and Assays Market Size (2018-2029)
1.6.1 North America Neuroscience Antibodies and Assays Market Size (2018-2029)
1.6.2 Europe Neuroscience Antibodies and Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2018-2029)
1.6.4 Latin America Neuroscience Antibodies and Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2018-2029)
2 Neuroscience Antibodies and Assays Market by Type
2.1 Introduction
2.1.1 Consumables
2.1.2 Instruments
2.2 Global Neuroscience Antibodies and Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuroscience Antibodies and Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuroscience Antibodies and Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuroscience Antibodies and Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuroscience Antibodies and Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuroscience Antibodies and Assays Revenue Breakdown by Type (2018-2029)
3 Neuroscience Antibodies and Assays Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical & Biotechnology Companies
3.1.2 Academic & Research Institutes
3.1.3 Hospitals & Diagnostic Centers
3.2 Global Neuroscience Antibodies and Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuroscience Antibodies and Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuroscience Antibodies and Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuroscience Antibodies and Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuroscience Antibodies and Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuroscience Antibodies and Assays Revenue Breakdown by Application (2018-2029)
4 Neuroscience Antibodies and Assays Competition Analysis by Players
4.1 Global Neuroscience Antibodies and Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2022)
4.3 Date of Key Players Enter into Neuroscience Antibodies and Assays Market
4.4 Global Top Players Neuroscience Antibodies and Assays Headquarters and Area Served
4.5 Key Players Neuroscience Antibodies and Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Neuroscience Antibodies and Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Profile
5.1.2 Thermo Fisher Main Business
5.1.3 Thermo Fisher Neuroscience Antibodies and Assays Products, Services and Solutions
5.1.4 Thermo Fisher Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Recent Developments
5.2 Abcam
5.2.1 Abcam Profile
5.2.2 Abcam Main Business
5.2.3 Abcam Neuroscience Antibodies and Assays Products, Services and Solutions
5.2.4 Abcam Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Abcam Recent Developments
5.3 Bio-Rad
5.3.1 Bio-Rad Profile
5.3.2 Bio-Rad Main Business
5.3.3 Bio-Rad Neuroscience Antibodies and Assays Products, Services and Solutions
5.3.4 Bio-Rad Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Neuroscience Antibodies and Assays Products, Services and Solutions
5.4.4 Merck Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Cell Signaling Technology
5.5.1 Cell Signaling Technology Profile
5.5.2 Cell Signaling Technology Main Business
5.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Products, Services and Solutions
5.5.4 Cell Signaling Technology Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Cell Signaling Technology Recent Developments
5.6 Genscript
5.6.1 Genscript Profile
5.6.2 Genscript Main Business
5.6.3 Genscript Neuroscience Antibodies and Assays Products, Services and Solutions
5.6.4 Genscript Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.6.5 Genscript Recent Developments
5.7 Rockland Immunochemicals
5.7.1 Rockland Immunochemicals Profile
5.7.2 Rockland Immunochemicals Main Business
5.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Products, Services and Solutions
5.7.4 Rockland Immunochemicals Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.7.5 Rockland Immunochemicals Recent Developments
5.8 BioLegend
5.8.1 BioLegend Profile
5.8.2 BioLegend Main Business
5.8.3 BioLegend Neuroscience Antibodies and Assays Products, Services and Solutions
5.8.4 BioLegend Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.8.5 BioLegend Recent Developments
5.9 Santa Cruz Biotechnology
5.9.1 Santa Cruz Biotechnology Profile
5.9.2 Santa Cruz Biotechnology Main Business
5.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Products, Services and Solutions
5.9.4 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Santa Cruz Biotechnology Recent Developments
5.10 Roche
5.10.1 Roche Profile
5.10.2 Roche Main Business
5.10.3 Roche Neuroscience Antibodies and Assays Products, Services and Solutions
5.10.4 Roche Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Roche Recent Developments
5.11 Siemens
5.11.1 Siemens Profile
5.11.2 Siemens Main Business
5.11.3 Siemens Neuroscience Antibodies and Assays Products, Services and Solutions
5.11.4 Siemens Neuroscience Antibodies and Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Siemens Recent Developments
6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuroscience Antibodies and Assays Market Dynamics
11.1 Neuroscience Antibodies and Assays Industry Trends
11.2 Neuroscience Antibodies and Assays Market Drivers
11.3 Neuroscience Antibodies and Assays Market Challenges
11.4 Neuroscience Antibodies and Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
